Somatic Cell Genome Editing (SCGE)
The NIH Common Fund’s Somatic Cell Genome Editing (SCGE) program aims to reduce the burden of diseases caused by genetic changes. Genome editing technologies present an exciting prospect for treatments and possibly even cure for these diseases. During its first 5-year phase (FY18-FY23), SCGE developed quality tools to perform and assess effective genome editing tools in non-reproductive (“somatic”) cells of the body. In its second phase (FY23-27), SCGE will accelerate the translation of genome editing therapies into the clinic. (Retrieved from the NIH Common Fund site)
Metadata and Processed Data Files
C2M2
0 Available Files
Current
None Available
Archived
None Available
XMT
1 Current File(s) | 0 Archived File(s)
1 Current File(s)
0 Archived File(s)
Modified 5/13/2025
Current
Filename:
study.smtCreator: SCGE
Filesize: 120.0 B
Date Modified: 5/13/2025
DCC Approved:
DRC Approved:
Archived
None Available
Attribute Tables
0 Available Files
Current
None Available
Archived
None Available
Knowledge Graph Assertions
0 Available Files
Current
None Available
Archived
None Available
Interoperability Assets
ETL Scripts
0 Available Files
Current
None Available
Archived
None Available
API Specifications
0 Available Files
Current
None Available
Archived
None Available
Entity Pages
0 Available Files
Current
None Available
Archived
None Available
PWB Metanodes
0 Available Files
Current
None Available
Archived
None Available
Models
0 Available Files
Current
None Available
Archived
None Available
Apps URLs
0 Available Files
Current
None Available
Archived
None Available